Ovulation induction in women with polycystic ovary syndrome

被引:39
作者
Perales-Puchalt, Alfredo [1 ]
Legro, Richard S. [1 ]
机构
[1] Penn State Univ, Coll Med, Dept Obstet & Gynecol, Hershey, PA USA
关键词
Ovulation induction; Polycystic ovary syndrome; Anovulation; Infertility; IN-VITRO FERTILIZATION; FOLLICLE-STIMULATING-HORMONE; AROMATASE INHIBITOR LETROZOLE; LOW-DOSE FSH; CLOMIPHENE CITRATE; WEIGHT-LOSS; INFERTILE WOMEN; DOUBLE-BLIND; LIVE-BIRTH; CLOMIFENE CITRATE;
D O I
10.1016/j.steroids.2013.05.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility. There are multiple ways to induce ovulation in PCOS patients, which will eventually provide a successful live birth. Each of these treatments varies in aggressiveness and effectiveness. Ranging from lifestyle modifications, through insulin-sensitizing agents, selective estrogen receptor modulators, aromatase inhibitors, gonadotropins, to laparoscopic ovarian drilling and assisted reproductive techniques, each method achieves ovulation induction through different mechanisms of action. This review provides a description and specific characteristics of the different methods used for ovulation induction which can help to design a personalized approach to each PCOS patient, and a general stepwise approach to ovulation induction in these patients. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:767 / 772
页数:6
相关论文
共 75 条
[1]
HORMONAL RESPONSE TO ELECTROCAUTERY OF THE OVARY IN PATIENTS WITH POLYCYSTIC OVARIAN DISEASE [J].
AAKVAAG, A ;
GJONNAESS, H .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1985, 92 (12) :1258-1264
[2]
INSULIN ENHANCEMENT OF LUTEINIZING-HORMONE AND FOLLICLE-STIMULATING-HORMONE RELEASE BY CULTURED PITUITARY-CELLS [J].
ADASHI, EY ;
HSUEH, AJW ;
YEN, SSC .
ENDOCRINOLOGY, 1981, 108 (04) :1441-1449
[3]
ADASHI EY, 1984, FERTIL STERIL, V42, P331
[4]
American College of Obstetricians and Gynecologists, 2013, Obstet Gynecol, V121, P213, DOI http://10.1097/01.AOG.0000425667.10377.60
[5]
[Anonymous], 2005, OBSTET GYNECOL, V106, P671
[6]
[Anonymous], 2011, COCHRANE DATABASE SY
[7]
ASCH RH, 1976, J REPROD MED, V17, P175
[8]
A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain [J].
Asunción, M ;
Calvo, RM ;
San Millán, JL ;
Sancho, J ;
Avila, S ;
Escobar-Morreale, HF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2434-2438
[9]
The prevalence and features of the polycystic ovary syndrome in an unselected population [J].
Azziz, R ;
Woods, KS ;
Reyna, R ;
Key, TJ ;
Knochenhauer, ES ;
Yildiz, BO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2745-2749
[10]
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selina F. .
FERTILITY AND STERILITY, 2009, 91 (02) :456-488